A signalome screening approach in the autoinflammatory disease TNF Receptor Associated Periodic Syndrome (TRAPS) highlights the anti-inflammatory properties of drugs for repurposing
TNF Receptor Associated Periodic Syndrome (TRAPS) is an autoinflammatory disease caused by mutations in TNF Receptor 1 (TNFR1). Current therapies for TRAPS are limited and do not target the pro-inflammatory signalling pathways that are central to the disease mechanism. Our aim was to identify drugs...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017
|
Online Access: | http://eprints.nottingham.ac.uk/46737/ http://eprints.nottingham.ac.uk/46737/ http://eprints.nottingham.ac.uk/46737/ http://eprints.nottingham.ac.uk/46737/1/Todd%20Negm%20et%20al%20PharmacolRes%20Manuscript_.pdf |